
With so many technologies for genetically modifying models, it pays to choose wisely
Listen to this article on the DDW Podcast: By Caroline Horizny, Taconic Biosciences When a pharmaceutical company, biotech firm, or academic institution embarks on a preclinical research project, one of the most critical early-stage decisions is which animal model will best support the project’s objective. Mouse models remain a go-to resource… Read More















